XML 21 R7.htm IDEA: XBRL DOCUMENT v3.7.0.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Jul. 29, 2017
Jul. 30, 2016
Cash flows from operating activities:    
Net income $ 379,609 $ 565,507
Adjustments to reconcile net income to net cash provided by operations:    
Depreciation 138,368 100,424
Amortization of intangibles 255,955 55,703
Cost of goods sold for inventory acquired 316,678 0
Stock-based compensation expense 71,839 48,187
Loss on extinguishment of debt 0 3,290
Excess tax benefit-stock options (30,235) (7,180)
Deferred income taxes 11,475 5,072
Other non-cash activity (18,613) 2,371
Changes in operating assets and liabilities (653,403) 20,537
Total adjustments 92,064 228,404
Net cash provided by operating activities 471,673 793,911
Cash flows from investing activities:    
Purchases of short-term available-for-sale investments (705,485) (5,855,930)
Maturities of short-term available-for-sale investments 3,362,791 5,010,942
Sales of short-term available-for-sale investments 577,187 290,071
Additions to property, plant and equipment (138,883) (86,173)
Payments for acquisitions, net of cash acquired (9,687,463) (2,203)
Changes in other assets (13,125) (18,048)
Net cash used for investing activities (6,604,978) (661,341)
Cash flows from financing activities:    
Payments of derivative instruments 0 (33,430)
Proceeds from debt 11,156,164 1,235,331
Payments of deferred financing fees (5,625) (22,208)
Proceeds from derivative instruments 3,904 0
Debt repayments (4,700,000) (378,156)
Dividend payments to shareholders (435,262) (383,537)
Repurchase of common stock (35,935) (368,649)
Proceeds from employee stock plans 105,244 39,342
Changes in other financing activities (7) (7,423)
Excess tax benefit-stock options 30,235 7,180
Net cash provided by financing activities 6,118,718 88,450
Effect of exchange rate changes on cash 2,024 (1,703)
Net (decrease) increase in cash and cash equivalents (12,563) 219,317
Cash and cash equivalents at beginning of period 921,132 884,353
Cash and cash equivalents at end of period $ 908,569 $ 1,103,670